Interstitial fibrosis progression at 1 year after kidney transplantation appeared no lower with corticosteroid use in low-risk patients. Corticosteroid use may not slow interstitial fibrosis ...

In a new study, researchers have discovered a connection between inflammation in the areas of interstitial fibrosis and tubular atrophy (IFTA).

Please provide your email address to receive an email when new articles are posted on . Annual incidence of asymptomatic pulmonary fibrosis in relatives of those with familial interstitial pneumonia ...

PPF is identified by decline in lung function, worsening symptoms, and increased fibrosis on imaging, with variable criteria across studies. Risk factors for PPF include older age, male sex, smoking, ...

PET-MPs may exacerbate IPF by inducing oxidative stress, mitochondrial damage, and inflammation in pulmonary cells, leading to chronic lung injury. The study identified AKT1, PIM1, and PIK3CD as core ...

The FDA has approved Jascayd (nerandomilast) as a treatment for a second lung disease, progressive pulmonary fibrosis, following the drug’s initial approval in October 2025 as a treatment for ...